logo

Salarius Pharmaceuticals, Inc. (SLRX)



Trade SLRX now with
  Date
  Headline
6/15/2021 7:40:31 AM Salarius Pharmaceuticals Initiates Phase 1/2 Trial Clinical Trial For Seclidemstat In Hematologic Cancers
1/21/2021 8:13:00 AM Salarius Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
1/13/2021 7:37:44 AM Salarius Receives Second Installment Of $1.7 Mln In Payments From CPRIT